Cargando…

Recent therapeutic advances in chronic lymphocytic leukemia

The last several years have witnessed a paradigm shift in the management of patients with chronic lymphocytic leukemia (CLL). The course of this very heterogeneous disease, traditionally treated with chemotherapeutic agents usually in combination with rituximab, typically has been characterized by r...

Descripción completa

Detalles Bibliográficos
Autores principales: Bose, Prithviraj, Gandhi, Varsha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664994/
https://www.ncbi.nlm.nih.gov/pubmed/29152232
http://dx.doi.org/10.12688/f1000research.11618.1